(Q73526612)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Do we need better prognostic factors in node-negative breast cancer? Pro: (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

C Thomssen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Jänicke

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

293-298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

The 1998 St. Gallen's Consensus Conference: an assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

Time trends in systemic adjuvant treatment for node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

Breast cancer prognostic factors: evaluation guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

Integrating prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

[Clinical and prognostic significance of tumor-associated proteases in gynecologic oncology]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900304-4

7 January 2021

10.1016/S0959-8049(99)00304-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708928%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference